Pharmaceuticals

Our Solution

Qpurpose Energy

Along with Novo Nordisk, we have created a software for small-molecule drug discovery that enables pharmaceutical companies to validate molecular candidates and support early-stage drug development.

A challenge pharmaceutical companies experience is drug discovery is a very expensive and time-consuming process.

What We Deliver

Exponential speedup & high accuracy

Our quantum algorithm, based on Gaussian Boson Sampling, delivers exponential speed-up over the classical Monte Carlo method used by existing docking platforms.

The algorithm runs on high-performance computers emulating quantum systems and provides improved performance in accuracy and runtime for pharmaceutical companies. When quantum computers mature, the same algorithm will integrate seamlessly for even greater performance.

The Results

Exceptional improvements

Our quantum software predicts 10x faster and improves docking accuracy by +43% compared to the world-leading software GNINA and +50% versus the commercial software used by major pharma companies for docking calculations, GLIDE.